A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care

By Sørensen Jan   Stage Kurt   Damsbo Niels   Lay Agathe Le   Hemels Michiel  

Nordic Journal of Psychiatry, Vol. 61, Iss. 2, 2007-01 ,pp. : 100-108

Informa Healthcare

Access to resources Recommend Favorite

Refining cost-effectiveness analyses using the net benefit approach and econometric methods: An example from a trial of anti-depressant treatment

By Sabes-Figuera Ramon  

Journal of Mental Health, Vol. 22, Iss. 2, 2013-04 ,pp. : 93-100

Informa Healthcare

Access to resources Recommend Favorite

Medication use, self-reported drug allergies, and estimated medication cost in patients with epileptic versus nonepileptic seizures - A cost-effectiveness comparison of alternative treatment options

By Reeves A.L.   McAuley J.W.   Moore J.L.   Capestany J.  

Journal of Epilepsy, Vol. 11, Iss. 4, 1998-07 ,pp. : 191-194

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness of 3-D cell counting

By Geuna S.  

Trends in Neurosciences, Vol. 24, Iss. 7, 2001-07 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite

Developing models for assessing the cost-effectiveness of antidepressants in primary care

By Thornett Andrew  

Primary Care Psychiatry, Vol. 7, Iss. 2, 2001-07 ,pp. : 69-74

Informa Healthcare

Access to resources Recommend Favorite